Works by Fitzgerald, Alison L.


Results: 7
    1

    Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.

    Published in:
    Dermatology & Therapy, 2024, v. 14, n. 3, p. 593, doi. 10.1007/s13555-024-01111-5
    By:
    • Wysong, Ashley;
    • Somani, Ally‐Khan;
    • Ibrahim, Sherrif F.;
    • Cañueto, Javier;
    • Fitzgerald, Alison L.;
    • Siegel, Jennifer J.;
    • Prasai, Anesh;
    • Goldberg, Matthew S.;
    • Farberg, Aaron S.;
    • Regula, Christie;
    • Bar, Anna;
    • Kasprzak, Julia;
    • Brodland, David G.;
    • Koyfman, Shlomo A.;
    • Arron, Sarah T.
    Publication type:
    Article
    2
    3
    4
    5

    Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.

    Published in:
    Diagnostic Pathology, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13000-022-01211-w
    By:
    • Borman, Sherri;
    • Wilkinson, Jeff;
    • Meldi-Sholl, Lauren;
    • Johnson, Clare;
    • Carter, Kelsey;
    • Covington, Kyle R.;
    • Fitzgerald, Alison L.;
    • Kurley, Sarah J.;
    • Farberg, Aaron S.;
    • Goldberg, Matthew S.;
    • Monzon, Federico A.;
    • Oelschlager, Kristen;
    • Cook, Robert W.
    Publication type:
    Article
    6
    7